1.
|
|
South East European International Institute for Sustainable Technologies (SEEIIST)
/ Amaldi, Ugo (TERA, Novara) ; Benedetto, Elena (TERA, Novara) ; Damjanovic, Sanja (SEEIIST Association) ; Dosanjh, Manjit (CERN ; U. Oxford (main)) ; Durante, Marco (Darmstadt, GSI ; Darmstadt, Tech. U.) ; Georgieva, Petya (TERA, Novara) ; Haberer, Thomas (HITS, Heidelberg) ; Plesko, Mark (Cosylab, Ljubljana) ; Ristova, Mimoza (SEEIIST Association ; Faculty of Natural Sciences, UKIM, Skopje, North Macedonia) ; Rossi, Sandro (CNAO) et al.
The South East European International Institute for Sustainable Technologies (SEEIIST) was proposed in 2016 at the World Academy of Art and Science, with the objective of building a facility for charged particle cancer therapy for the South Eastern European countries. [...]
15 p.
Full text
|
|
2.
|
South East European International Institute for Sustainable Technologies (SEEIIST)
/ Amaldi, Ugo (TERA, Novara) ; Benedetto, Elena (TERA, Novara) ; Damjanovic, Sanja (Unlisted, CH) ; Dosanjh, Manjit (CERN) ; Durante, Marco (Darmstadt, GSI ; Darmstadt, Tech. U.) ; Georgieva, Petya (TERA, Novara) ; Haberer, Thomas (HITS, Heidelberg) ; Plesko, Mark (Cosylab, Ljubljana) ; Ristova, Mimoza (CERN ; Skopje U.) ; Rossi, Sandro (Unlisted, IT) et al.
The South East European International Institute for Sustainable Technologies (SEEIIST) was
proposed in 2016 at the World Academy of Art and Science, with the objective of building a
facility for charged particle cancer therapy for the South Eastern European countries. SEEIIST
will offer the world-class research needed to reduce or even revert the brain drain that is causing
a shortage of talent and economic losses in South East Europe. [...]
2021
- Published in : Front. Phys. 8 (2021) 567466
|
|
3.
|
Patients With Cancer in the Countries of South-East Europe (the Balkans) Region and Prospective of the Particle Therapy Center: South-East European International Institute for Sustainable Technologies (SEEIIST)
/ Ristova, Mimoza M (CERN ; Skopje U. ; SEEIIST, Geneva) ; Gershan, Vesna (Skopje U.) ; Schopper, Herwig (CERN ; SEEIIST, Geneva) ; Amaldi, Ugo (TERA, Novara) ; Dosanjh, Manjit (CERN ; Oxford U.)
Purpose: A recent initiative was launched for establishing the South-East European International Institute for Sustainable
Technologies (SEEIIST), which will provide a cutting-edge Hadron radiation therapy treatment and research institute for treating
cancer patients with Hadron therapy (HT). To justify the initiative for building the SEEIIST facility, a study was conducted to
estimate the number of patients with cancer from the SEE region that would be eligible for HT.
Methods and Materials: Two different methods for projecting the future annual cancer incidence have been applied: (1) using the
International Agency on Research on Cancer@World Health Organization’s (WHO) Globocan model which uses country’s
demographic factors, and (2) averaging the crude incidence data of 3 SEE countries with available national cancer registries, using a
linear regression model of combined incidence per 100,000, and applying it to the entire SEE region. [...]
2021 - 10 p.
- Published in : Advances in Radiation Oncology 6 (2021) 100772
Fulltext: PDF;
|
|
4.
|
Availability of technology for managing cancer patients in the Southeast European (SEE) region
/ Dosanjh, Manjit (CERN ; Int. Cancer Expert Corps, Washington) ; Ristova, Mimoza (CERN ; Skopje U.) ; Gershan, Vesna (Skopje U.) ; Georgieva, Petya (CERN) ; Balin Kovacevic, Marijana ; Bregu, Ledio ; Coralic, Irma ; Djurovic, Tamara ; Dosieva, Deyana ; Foka, Yiota (CERN ; Darmstadt, GSI) et al.
Background: The Southeast European (SEE) region of 10 countries and about 43 million people differs from
Western Europe in that most SEE countries lack active cancer registries and have fewer diagnostic imaging
devices and radiotherapy (RT) units. The main objective of this research is to initiate a common platform for
gathering SEE regional cancer data from the ground up to help these countries develop common cancer management strategies.
Methods: To obtain detailed on-the-ground information, we developed separate questionnaires for two SEE
groups: a) ONCO - oncologists regarding cancer treatment modalities and the availability of diagnostic imaging and radiotherapy equipment; and b) REG - national radiation protection and safety regulatory bodies regarding
diagnostic imaging and radiotherapy equipment in SEE facilities.
Results: Based on responses from 13/17 ONCO participants (at least one from each country) and from 9/10 REG
participants (all countries but Albania), cancer incidence rates are higher in those SEE countries that have greater
access to diagnostic imaging equipment while cancer mortality-to-incidence (MIR) ratios are higher in countries
that lack radiotherapy equipment.
Conclusion: By combining unique SEE region information with data available from major global databases, we
demonstrated that the availability of diagnostic imaging and radiotherapy equipment in the SEE countries is
related to their economic development. [...]
2022 - 10 p.
- Published in : Clinical and Translational Radiation Oncology 34 (2022) 57-66
Fulltext: PDF;
|
|
5.
|
EuCARD Newsletter Issue 3
/ Kahle, K L M (CERN) ; Koutchouk, J P (CERN) ; Spiller, P (Darmstadt, GSI) ; Bozyk, L (Darmstadt, GSI) ; Pascoli, S (Durham U., IPPP) ; Amaldi, U (Milano Bicocca U. ; TERA, Novara)
WP: 2: DCO: Dissemination, Communication & Outreach
Task: 2.2: Dissemination & Outreach
European Coordination for Accelerator Research and Development (EuCARD) Newsletter Issue 3: October - December 2009 * A word on behalf of the Steering Committee * Cryocatcher in the GSI * Strategy and the Spallation Source * Accelerators for hadron therapy * For EuCARD members: publications
EuCARD-MIS-2009-4.
-
2009.
Full text
|
|
6.
|
|
|
A novel facility for cancer therapy and biomedical research with heavy ions for the South East European International Institute for Sustainable Technologies
/ Damjanovic, Sanja (SEEIIST Association (CH)) ; Amaldi, Ugo (TERA Foundation (IT)) ; Benedetto, Elena (SEEIIST Association (CH)) ; Bisoffi, Giovanni (Universita e INFN, Legnaro (IT)) ; Dosanjh, Manjit ; Durante, Marco ; Foka, Yiota (GSI - Helmholtzzentrum fur Schwerionenforschung GmbH (DE)) ; Grubling, Peter (SEEIIST Association (CH)) ; Rossi, Sandro ; Sapinski, Mariusz (SEEIIST Association (CH)) et al.
The South East European International Institute for Sustainable Technologies (SEEIIST) proposes the construction of a major joint Research Infrastructure in the region, to rebuild cooperation after the recent wars and overcome lasting consequences like technology deficits and brain drain, having at its core a facility for cancer therapy and biomedical research with heavy ions. [...]
CERN-ACC-NOTE-2021-0019 ; NIMMS-Note-005.
-
2021. - 4 p.
Full text - Full text
|
|
7.
|
ebook
|
8.
|
Changing the global radiation therapy paradigm
/ Pistenmaa, David A (International Cancer Expert Corps, Inc., Washington, DC, USA) ; Dosanjh, Manjit (CERN) ; Amaldi, Ugo (TERA, Novara) ; Jaffray, David (Toronto U. ; University Health Network, Canada) ; Zubizarreta, Eduardo (IAEA, Vienna) ; Holt, Katherine (Dept. of Energy, Wash., D.C.) ; Lievens, Yolande (Ghent University hospital, belgium ; European Society for Radiotherapy and Oncology, Brussels, Belgium) ; Pipman, Yakov (Medical Physics for World Benefit, USA) ; Coleman, C Norman (International Cancer Expert Corps, Inc., Washington, DC, USA)
2018 - 7 p.
- Published in : Radiotherapy Oncology 128 (2018) 393-399
|
|
9.
|
The next ion medical machine study at CERN: Towards a next generation cancer research and therapy facility with ion beams
/ Vretenar, Maurizio (CERN) ; Bencini, Vittorio (TERA Foundation (IT)) ; Khalvati, Mohammad Reza ; Lombardi, Alessandra (CERN) ; Tommasini, Davide (CERN) ; Benedetto, Elena (SEEIIST Association (CH)) ; Sapinski, Mariusz (SEEIIST Association (CH)) ; Foka, Yiota (GSI - Helmholtzzentrum fur Schwerionenforschung GmbH (DE))
Cancer therapy with ions has several advantages over X- ray and proton therapy, but its diffusion remains limited primarily because of the size and cost of the accelerator. To develop technologies that might improve performance and reduce accelerator cost with respect to present facilities, CERN has recently launched the Next Ion Medical Ma-chine Study (NIMMS), leveraging CERN expertise in accelerator fields to disseminate technologies developed for basic science. [...]
CERN-ACC-NOTE-2021-0018; NIMMS-Note-004.-
Geneva : CERN, 2021 - 6 p.
- Published in : JACoW IPAC2021 (2021) MOPAB413
Fulltext: document (3) - ; NIMMS_Note_004_Final - PDF;
In : 12th International Particle Accelerator Conference (IPAC 2021), Online, 24 - 28 May 2021, pp.MOPAB413
|
|
10.
|
|